Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
about
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciManagement of multidrug-resistant enterococcal infectionsA potential role for daptomycin in enterococcal infections: what is the evidence?Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.Enterococcal endocarditis: can we win the war?In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.A current perspective on daptomycin for the clinical microbiologist.Therapeutic options for vancomycin-resistant enterococcal bacteremia.Enterococcal endocarditis revisited.Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Tigecycline: Alone or in combination?Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis.What's New in the Treatment of Enterococcal Endocarditis?Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy.Endocarditis caused by resistant enterococcus: an overview.Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009).Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.
P2860
Q26851754-D62ACE9C-9DA4-47E0-885F-9C4B21CF5AF1Q28285907-748D8FAD-0C31-4D26-96A3-46524A8865A6Q33845776-72FF6126-5D03-474B-AC56-8232AD748EFAQ34736204-39BEF250-FA7C-4E57-830A-12B8A9F7B739Q35610638-1C8E0BF4-5298-4A15-8C5C-E7CF6FA19D21Q35746209-89ED5191-826A-4743-A7FA-1C381A95CFD5Q37263289-036F4963-4E99-4C9F-81DB-69D9F493FB37Q38347869-D33CA93D-192D-4DC7-8E7B-8CA4D80C55CEQ38539279-435BA44C-C375-42CA-9E7C-6C0E0195D8E8Q38577676-FFF9E948-4331-4A51-9D98-0B513FA52CC5Q39168565-61AA3F6E-D777-4F2A-BEFE-F430DA743E74Q39916184-F9DF0847-F326-4D0F-80CD-DEDEE537DA95Q40201824-D775E9FE-9981-4684-9A06-484BD656030BQ41368979-184F71E9-2EB7-4B30-8205-325982C63B86Q41443025-C210CB9A-381D-43C7-A05A-FB78A6291256Q42228134-F31B8B63-72B6-48CB-AFE7-8F5E8F7D88CAQ42259672-EC551FDD-62F7-4DD1-B0C4-D657BDF0F7EAQ44579110-3463F428-96EA-4C72-A74F-E00EBD5BCEAAQ46556054-CCA710D7-726E-46B2-AF36-EF3D41AE744CQ49446863-4546248C-1AB9-4DE2-ABC3-F92FDB07B36F
P2860
Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@en
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@nl
type
label
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@en
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@nl
prefLabel
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@en
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@nl
P2860
P356
P1476
Multidrug-resistant Enterococc ...... line and high-dose daptomycin.
@en
P2093
Amanda C Schutt
Nicole M Bohm
P2860
P304
P356
10.1345/APH.1M324
P407
P577
2009-11-03T00:00:00Z